Alcohol dependence (AD) is a serious public health concern and contributes to 1.8 million deaths worldwide (
WHO: Global Burden of Disease, 2009). In the U.S. alone, 11% of the adult population meets criteria for DSM-IV AD during their lifetime and 26% of those who drink alcohol endorse at least one dependence criterion during their lifetime (
Grant et al., 2004;
Saha et al., 2006). A consistently studied contributor to severity of alcohol dependence is age at first drink - according to the National Household Survey of Drug Use and Health (
Substance Abuse and Mental Health Services Administration (SAMHSA), 2005) 86% of alcohol initiates in the U.S. are aged 20 or younger (mean age at 1
st drink of 16.8 years). A wealth of epidemiological research suggests that underage drinking, particularly initiation of alcohol use at a young age, is associated with increased alcohol involvement, including heavier drinking, DUIs (
Hingson et al., 2001;
Hingson et al., 2002;
Hingson et al., 2000;
Hingson et al., 2004;
Hingson et al., 2006;
Hingson et al., 2008;
Lynskey et al., 2007) and importantly, alcohol dependence (
Chou and Pickering, 1992;
Dawson et al., 2008;
Grant and Dawson, 1997;
Hingson et al., 2006;
McGue et al., 2001b) as well as other disinhibitory behaviors (
Hingson et al., 2008;
McGue et al., 2001b) and drug use. Results emerging from two large scale epidemiological studies representative of the U.S. population show a 1.3–1.6 times increased risk for AD in those who initiate alcohol use at 15 years of age or younger and a corresponding reduction in risk for alcohol dependence (by 14%) with each one-year delay in alcohol initiation (
Dawson et al., 2008;
Grant and Dawson, 1997). These findings were in keeping with findings from a Canadian sample, where the increased risk for AD in early-onset drinkers persisted even after controlling for exposure to childhood trauma and psychopathology (
DeWit et al., 2000).
A small number of genetically informative studies have investigated the association between age at 1
st drink and AD. Using a sample of adult Virginia twins,
Prescott & Kendler (1999) found that the prevalence of AD declined with increasing age at 1
st drink, that one twin’s age at 1
st drink was predictive of their co-twin’s AD and importantly, that the relationship between age at 1
st drink and AD was attributable to a substantial degree to common genetic influences (18–29% genetic overlap). Grant and colleagues (
Grant et al., 2005) used a similar strategy to assess age at first drink and AD in a sample of adult male Vietnam Era twins and reported that early (prior to age 17) regular alcohol use in one twin led to a 2.7 times increased likelihood of AD in the identical co-twin. These authors also reported a substantial correlation (0.59–0.64) between early regular drinking and AD. In a third study, Sartor and colleagues, using an offspring-of-twins design, found considerable evidence for increased risk of AD in those with an early age at 1
st drink, but, importantly, did not find evidence that this risk varied by (paternally transmitted) genetic risk for AD (
Sartor et al., 2007).
There is now overwhelming evidence suggesting that heritable influences play a substantial role in AD diagnoses and symptomatology (
Heath, 2007;
Kendler et al., 1992;
McGue, 1999; Prescott et al., 1994). Additionally, there is support for familial influences on age at 1
st drink (
McGue et al., 2001a) and, as described above, there appears to be considerable genetic overlap between age at 1
st drink and AD (
Grant et al., 2005;
Prescott and Kendler, 1999). However, age at 1
st alcohol use can also be viewed as an environmental measure. In fact, neither
Prescott and Kendler (1999) nor
Grant et al. (2005) could unequivocally rule out the environmental impact of age at 1
st (or regular) drink on AD. If early exposure to alcoholic beverages is an environmental measure, then it can be related to the highly heritable AD phenotypes (i.e., diagnosis and symptomatology) in multiple ways. First, its relationship with AD may be viewed in the context of unmeasured gene-measured environment correlation (or rGE) where the same latent/unmeasured genetic factors that induce individual differences in AD phenotypes also increase the likelihood of exposure to alcohol at an early age (
Scarr, 1992;
Scarr and McCartney, 1983). This could occur passively, through parental drinking behaviors or actively, through seeking out (like) peers who engage in problem behaviors that include early substance use.
Two independent studies have found evidence for rGE and for the possibility that common genetic etiology underlies age at 1
st drink and AD (
Grant et al., 2005;
Prescott and Kendler, 1999). An alternative putative relationship between age at 1
st drink and AD phenotypes, specifically, whether there is an unmeasured gene x measured environment (GxE) interaction, however, has not been previously examined. That is, after controlling for the main effects of rGE (i.e., those with an early age at 1
st drink will have a greater likelihood of AD), to what extent does early exposure to alcohol moderate the role of genetic (and environmental) influences on later AD symptomatology? A GxE interaction implies that genetic influences on AD symptoms are moderated by early exposure to alcohol such that these genetic influences gain prominence (i.e., high heritability) only when there is exposure to the high risk environment, in this case, initiation of alcohol use at an early age (
Gunzerath and Goldman, 2003;
Heath et al., 2002;
Heath and Nelson, 2002;
Martin et al., 1987). Viewed another way, a GxE interaction may be interpreted as follows: individuals with genetic influences predisposing them to AD will be more likely to develop AD symptomatology if they are exposed to alcohol at an early age. A GxE interaction would therefore imply that, even in the presence of genetic vulnerability, delaying exposure to alcohol use will reduce the emergence of AD symptomatology.
In the current study, we use data on 6,257 adult male and female Australian twins to examine whether age at 1st drink modifies the extent to which genetic and environmental factors influence individual differences in DSM-IV AD symptoms.